Table 1

Characteristic of 30 patients
Age (year) 32-80 (mean 64)
Gender
 Male 25
 Female 5
Histology
 Clear cell 23
 Papillary 5
 Clear/Sarcomatoid 1
 Clear/Papillary 1
TKI treatment
 Sunitinib 16
 Sorafenib 14
MSKCC classification
 Favorable 1
 Intermediate 21
 Poor 8
Nephrectomy
 Yes 22
 No 8
Prior treatment
 Non 19
 IFN-α 9
 Sorafenib 3
 Chemotherapy 2

Ueno et al.

Ueno et al. BMC Cancer 2012 12:162   doi:10.1186/1471-2407-12-162

Open Data